MyPharmacy+

Lrzin Powder Lemony Orange

Manufactured By Bharat Serums & Vaccines Ltd

Salt Synonyms

Rs. 41.80

MRP 44.00

(5% OFF)

Includes all taxes

Package SIZE

sachet of 10 gm Powder

Price may vary depending on the product batch*

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Lrzin Powder Lemony Orange

Uses / Indications:

Take 60-100 ml of water in a glass|Add a spoonful of Lrzin Powder Lemony Orange to the glass|Mix the powder thoroughly and drink immediately

Introduction:

Lrzin Powder Lemony Orange contains L-Arginine and Zinc Sulphate Monohydrate designed to support pregnant mothers. This powder helps improve blood flow supports fetal growth and ensures a healthy progression of pregnancy. The lemony orange flavour makes it a pleasant addition to the daily routine of expectant mothers.

How to use:

May enhance blood flow to support the health and development of both the mother and the fetus|May be essential for the growth and development of the fetus|Zinc supports various enzymatic functions in the body aiding in cell growth division and overall immune function

Description:

Supports healthy pregnancy and fetal development|Improves blood flow and circulation|Contains essential nutrients for expectant mothers|Pleasant lemony orange flavor

Benefits:

Safety Advise:

Lrzin Powder Lemony Orange

Manufactured By Bharat Serums & Vaccines Ltd

Salt Synonyms

Rs. 41.80

MRP 44.00

Includes all taxes

Package SIZE

Available Substitutes

1M Liquid

Ozone Pharmaceuticals Ltd

1M Moisturising Cream Wash

Ozone Pharmaceuticals Ltd

1ratti Ashokarishta (450ml Each)

1ratti- Ratti Ratti Me Purity

2 Sitol Chewable Tablet

Premier Nutraceuticals Pvt Ltd

2 Soft Vaginal Wash

Captab Biotec

Uses / Indications:

Introduction:

How to use:

Description:

Benefits:

Safety Advise:

If you miss a dose:

Fact Box:

Primary Use:

Common Side Effects:

Alcohol Interaction:

Pregnancy Interaction:

Lactation Interaction:

Driving Interaction:

Kidney Interaction:

Liver Interaction:

Q&A: